ATE323184T1 - Verfahren zur herstellung von blutplasmaprodukten durch ausschluss von spenden mit hohen parvo-b19- virenkonzentrationen - Google Patents

Verfahren zur herstellung von blutplasmaprodukten durch ausschluss von spenden mit hohen parvo-b19- virenkonzentrationen

Info

Publication number
ATE323184T1
ATE323184T1 AT98120799T AT98120799T ATE323184T1 AT E323184 T1 ATE323184 T1 AT E323184T1 AT 98120799 T AT98120799 T AT 98120799T AT 98120799 T AT98120799 T AT 98120799T AT E323184 T1 ATE323184 T1 AT E323184T1
Authority
AT
Austria
Prior art keywords
blood plasma
parvo
donations
excluding
plasma products
Prior art date
Application number
AT98120799T
Other languages
German (de)
English (en)
Inventor
Thomas Dr Weimer
Albrecht Dr Groener
Original Assignee
Zlb Behring Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7850168&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE323184(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zlb Behring Gmbh filed Critical Zlb Behring Gmbh
Application granted granted Critical
Publication of ATE323184T1 publication Critical patent/ATE323184T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT98120799T 1997-11-28 1998-11-03 Verfahren zur herstellung von blutplasmaprodukten durch ausschluss von spenden mit hohen parvo-b19- virenkonzentrationen ATE323184T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752898A DE19752898A1 (de) 1997-11-28 1997-11-28 Verfahren zum Nachweis hoher Vierenkonzentrationen im Blutplasma und/oder Blutserum mittels der Polymerasekettenreaktion

Publications (1)

Publication Number Publication Date
ATE323184T1 true ATE323184T1 (de) 2006-04-15

Family

ID=7850168

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98120799T ATE323184T1 (de) 1997-11-28 1998-11-03 Verfahren zur herstellung von blutplasmaprodukten durch ausschluss von spenden mit hohen parvo-b19- virenkonzentrationen

Country Status (8)

Country Link
US (1) US6183999B1 (enExample)
EP (1) EP0922771B1 (enExample)
JP (2) JPH11225797A (enExample)
KR (1) KR100648843B1 (enExample)
AT (1) ATE323184T1 (enExample)
CA (1) CA2252013C (enExample)
DE (2) DE19752898A1 (enExample)
ES (1) ES2259196T3 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT410218B (de) * 1999-08-20 2003-03-25 Baxter Ag Verfahren zur herstellung eines qualitätsgesicherten pools biologischer proben
JP2005511004A (ja) 2001-06-28 2005-04-28 カイロン コーポレイション パルボウイルスｂ１９についての診断アッセイ
US7094541B2 (en) * 2001-08-31 2006-08-22 Gen-Probe Incorporated Assay for detection of human parvovirus B19 nucleic acid
EP1521849A4 (en) * 2001-10-12 2006-05-17 Chiron Corp HEPATITIS A-VIRUS NUCLEOTIDE SEQUENCES, RECOMBINANT PROTEINS AND THEIR USE
EP2251441B1 (en) * 2004-02-10 2013-05-08 F. Hoffmann-La Roche AG Detection of parvovirus B19
WO2006031608A2 (en) * 2004-09-10 2006-03-23 Focus Diagnostics, Inc. Methods and compositions for detecting erythrovirus genotypes
AU2007233252C1 (en) 2006-03-29 2013-05-23 Boehringer Ingelheim Animal Health USA Inc. Vaccine against Streptococci
AU2012236109A1 (en) * 2011-04-01 2013-11-21 Occam Biolabs, Inc. Methods and kits for detecting cell-free pathogen-specific nucleic acids

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210015A (en) * 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5538848A (en) * 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
CA2159044A1 (en) * 1994-09-26 1996-03-27 Falko-Guenter Falkner Method of quantitating nucleic acids
AT406019B (de) * 1995-05-08 2000-01-25 Immuno Ag Verfahren zur herstellung eines arzneimittels enthaltend ein oder mehrere plasmaderivate
AT403477B (de) * 1996-04-30 1998-02-25 Immuno Ag Biologisches material frei von viralen und molekularen pathogenen und verfahren zur herstellung

Also Published As

Publication number Publication date
JPH11225797A (ja) 1999-08-24
CA2252013C (en) 2011-12-20
US6183999B1 (en) 2001-02-06
JP2006335764A (ja) 2006-12-14
DE19752898A1 (de) 1999-08-05
EP0922771A2 (de) 1999-06-16
EP0922771B1 (de) 2006-04-12
KR19990045625A (ko) 1999-06-25
EP0922771A3 (de) 2002-10-09
DE59813486D1 (de) 2006-05-24
KR100648843B1 (ko) 2007-03-02
ES2259196T3 (es) 2006-09-16
CA2252013A1 (en) 1999-05-28

Similar Documents

Publication Publication Date Title
DK10787D0 (da) Fremgangsmaade til detektering eller undersoegelse af tilstedevaerelseeller fravaer af en nucleinsyresekvens, som i det vaesentlige er bevaret, blandt isolater fra virus samt kit til anvendelse ved udoevelse af fremgangsmaaden
DK430384A (da) Fremgangsmaade til paavisning, identificering og kvantitativ bestemmelse af organismer og virus
Buck et al. Biophysical properties of Penicillium stoloniferum virus S.
Hruby et al. Encephalomyocarditis virus RNA. III. Presence of a genome-associated protein
ATE428003T1 (de) Oligonukleotidprimer zur effizienten detektion von hepatitis c virus (hcv) sowie verwendungsverfahren
ATE191513T1 (de) Verfahren zur amplifikation von nukleinsäuren
ATE92538T1 (de) Verstaerkung und nachweis von nukleinsaeuresequenzen.
ATE281647T1 (de) Verfahren zur typisierung von hepatitis c viren und dafür zu verwendende reagenzien
DK175846B1 (da) Fremgangsmåde til fremstilling af humant serum albumin ved hjælp af gær
ATE179459T1 (de) Verfahren zur typisierung von hcv-isolaten
DE69329800D1 (de) Detektion von gensequenzen in biologischen flüssigkeiten
DK0776981T3 (da) Oligonucleotidprimere til amplifikation af HCV-nukleinsyre
DE60105411D1 (de) Verfahren zur diagnose von krebs
ATE323184T1 (de) Verfahren zur herstellung von blutplasmaprodukten durch ausschluss von spenden mit hohen parvo-b19- virenkonzentrationen
Scholtissek et al. Binding of ribonucleic acids to the RNP-antigen protein of influenza viruses
GB1488774A (en) Hepatitis b antigen and method of producing it
Martin et al. The replication of Semliki Forest virus
Fenwick et al. Phosphorylation of a ribosomal protein and of virus-specific proteins in cells infected with herpes simplex virus
NZ510704A (en) An in vitro activity assay using the 5' oligonucleotide of human HBV DNA polymerase which has been incorporated into the SP6 viral polymerase promoter
DK232187D0 (da) Fremgangsmaade og apparat til detektion af virale dna og rna genomer i biologiske medier, navnlig i blodserum
Andzhaparidze et al. Mumps virus-persistently infected cell cultures release defective interfering virus particles
MX9205203A (es) Sonda que incluye acidos nucleicos para la deteccion de virus de arn de la hepatitis c
DE60015210D1 (de) Oligonukleotid Primer zur effizienten reversen Transkription von Hepatitis C Virus (HCV) RNS und Verfahren zu deren Verwendung
Huppert et al. Newcastle disease virus: virus particle and RNA synthesis in different host cells and at different temperatures
McCarthy et al. Intracellular nucleocapsid RNA of mumps virus

Legal Events

Date Code Title Description
EEFA Change of the company name